DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$13.20
0.29 (2.25%)
▲
5d:
+7.14%
30d:
+25.36%
90d:
+38.36%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DCTH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DCTH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $13.20, which is considered extended relative to its 30-day fair value range of $10.79 to $12.44. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.9) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.35 (+61.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.35 (+61.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.79 -
$12.44
Company Quality Score
60/100
(HOLD)
Options IV Signal
67th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- NEUTRAL: Options fairly priced (IV 67th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.8% below Wall St target ($21.35)
Trading Range Analysis
30-Day Trading Range
$10.79 -
$12.44
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.13
(16.2%)
Support & Resistance Levels
Support Level
$10.20
Resistance Level
$12.17
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.88
Wall Street Target
$21.35
(+61.8%)
Revenue Growth (YoY)
26.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
0.6%
PE vs Historical
-25.9 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: July 02, 2026 10:54 PM ET
Data refreshes hourly during market hours. Next update: 11:54 PM
Data refreshes hourly during market hours. Next update: 11:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
